Cancer, Malaria & TB Vaccinesv
Malaria continues to claim an estimated 2 to 3 million lives annually and to cause unimaginable misery for the 300 to 500 million people who contract it on a yearly basis. Due in large part to the spread of parasite strains that are safe for treatment, the decay of the healthcare system, and difficulties in implementing and maintaining vector control programs in many developing countries, jungle fever is considered to be a reemerging disease. People get jungle fever from four different protozoan parasite types: Plasmodium falciparum, P. vivax, P. malaria, and P. oval. The majority of fatalities and the vast majority of severe illnesses, including cerebral jungle fever, are caused by P. falciparum. 2 billion people with M. tuberculosis who are inactive 5–10% of those exposed get illness. Every year, there are 9 million new cases of TB. Annual TB deaths total 1.5 million. equivalent to 20 passenger aircraft crashes each day. TB is spread by adults who have citatory illness. People with HIV worry about the illness's more serious concerns. Most extreme TB horribleness and mortality, as compared to more mature children and adults, as well as the highest risk of progression from TB contamination to active infection.
- AS01 Vaccine
- RTS, S
Related Conference of Cancer, Malaria & TB Vaccinesv
Cancer, Malaria & TB Vaccinesv Conference Speakers
Recommended Sessions
- HIV Vaccines
- Cancer, Malaria & TB Vaccinesv
- Combination & Conjugate Vaccines
- DNA & Synthetic Vaccines
- Human Vaccines Against Infectious Diseases
- New Trends in Vaccines Development
- Pediatric Vaccines
- RDT in Antibiotic Research
- Side-effects of Vaccines
- Toxoid Vaccines
- Vaccine Production & Development
- Vaccine Safety & Efficacy
- Vaccines
- Vaccines for Pregnant Women
- Vaccines for Unconventional Diseases
- Vaccines Manufacturing Technologies
- Vaccines Research and Clinical Trails
- Zika Virus Vaccines
Related Journals
Are you interested in
- Antimicrobial Resistance (AMR) - VACCINES WORLD 2025 (Italy)
- Bioprocessing and Manufacturing - VACCINES WORLD 2025 (Italy)
- Cancer Vaccines and Immunotherapy - VACCINES WORLD 2025 (Italy)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2025 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2025 (France)
- Clinical Trials - VACCINES WORLD 2025 (Italy)
- Conjugate Vaccine - VACCINES WORLD 2025 (Italy)
- Coronavirus (COVID-19) & Pandemic Vaccines - VACCINES WORLD 2025 (Italy)
- DNA Vaccines - Euro Vaccines 2025 (France)
- DNA-RNA Vaccines - VACCINES WORLD 2025 (Italy)
- Emerging and Re-Emerging Diseases - VACCINES WORLD 2025 (Italy)
- Fungal/Bacterial/Viral/Parasitic/STD Vaccines - VACCINES WORLD 2025 (Italy)
- Hepatitis Vaccines - Euro Vaccines 2025 (France)
- HIV Vaccines - VACCINES WORLD 2025 (Italy)
- HIV/AIDS Vaccines - Euro Vaccines 2025 (France)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2025 (France)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2025 (France)
- Immune Profiling - VACCINES WORLD 2025 (Italy)
- Immunology/Animal Models - Euro Vaccines 2025 (France)
- Infectious and Non-Infectious Diseases - VACCINES WORLD 2025 (Italy)
- Influenza and Respiratory Vaccines - VACCINES WORLD 2025 (Italy)
- Mucosal Vaccines - Euro Vaccines 2025 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2025 (France)
- Thermo Stabilized Vaccines - VACCINES WORLD 2025 (Italy)
- Vaccine Adjuvants - Euro Vaccines 2025 (France)
- Vaccine Adjuvants - VACCINES WORLD 2025 (Italy)
- Vaccine Production, Supply & Logistics - VACCINES WORLD 2025 (Italy)
- Vaccine Research & Development - Euro Vaccines 2025 (France)
- Vaccine Research and Development - VACCINES WORLD 2025 (Italy)
- Vaccine Safety, Efficacy & Regulatory Affairs - VACCINES WORLD 2025 (Italy)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2025 (France)
- Vaccines Business Development - Euro Vaccines 2025 (France)
- Vaccines for Older Adults - Euro Vaccines 2025 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2025 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2025 (France)
- Vaccines Safety & Efficacy - Euro Vaccines 2025 (France)
- Veterinary Vaccine - VACCINES WORLD 2025 (Italy)
- Veterinary Vaccines - Euro Vaccines 2025 (France)